↓ Skip to main content

Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation

Overview of attention for article published in Pharmaceutics, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation
Published in
Pharmaceutics, January 2021
DOI 10.3390/pharmaceutics13010059
Pubmed ID
Authors

Norfatin Izzatie Mohamad Saimi, Norazlinaliza Salim, Noraini Ahmad, Emilia Abdulmalek, Mohd Basyaruddin Abdul Rahman

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Researcher 6 10%
Student > Ph. D. Student 4 7%
Student > Bachelor 3 5%
Professor 1 2%
Other 3 5%
Unknown 35 57%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 9 15%
Biochemistry, Genetics and Molecular Biology 5 8%
Medicine and Dentistry 3 5%
Chemical Engineering 2 3%
Chemistry 2 3%
Other 5 8%
Unknown 35 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#20,674,650
of 25,397,764 outputs
Outputs from Pharmaceutics
#3,942
of 6,525 outputs
Outputs of similar age
#396,050
of 519,751 outputs
Outputs of similar age from Pharmaceutics
#196
of 351 outputs
Altmetric has tracked 25,397,764 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,525 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,751 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 351 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.